My NCBISign In
Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer
Louise R Howe
Breast Cancer Res. 2007; 9(4): 210. Published online 2007 July 16. doi: 10.1186/bcr1678
PMCID:
PMC2206709
Abstract Full Text PDF–1.3M

Is Cited by the Following 29 Articles in this Archive:

Coffee intake and breast cancer risk in the NIH-AARP Diet and Health Cohort Study
Gretchen L. Gierach, Neal D. Freedman, Abegail Andaya, Albert R. Hollenbeck, Yikyung Park, Arthur Schatzkin, Louise A. Brinton
Int J Cancer. Author manuscript; available in PMC 2013 July 15.
Published in final edited form as: Int J Cancer. 2012 July 15; 131(2): 452–460. Published online 2011 October 20. doi: 10.1002/ijc.26372
PMCID:
PMC3290744
Free in PMC on 2013/07/15
Integrin α3β1 as a breast cancer target
Sita Subbaram, C. Michael DiPersio
Expert Opin Ther Targets. Author manuscript; available in PMC 2012 October 1.
Published in final edited form as: Expert Opin Ther Targets. 2011 October; 15(10): 1197–1210. Published online 2011 August 13. doi: 10.1517/14728222.2011.609557
PMCID:
PMC3212412
Free in PMC on 2012/10/01
Quercetin Suppresses Cyclooxygenase-2 Expression and Angiogenesis through Inactivation of P300 Signaling
Xiangsheng Xiao, Dingbo Shi, Liqun Liu, Jingshu Wang, Xiaoming Xie, Tiebang Kang, Wuguo Deng
PLoS One. 2011; 6(8): e22934. Published online 2011 August 8. doi: 10.1371/journal.pone.0022934
PMCID:
PMC3152552
Abstract Full Text PDF–833K
The Anti-Cancer and Anti-Inflammatory Actions of 1,25(OH)2D3
Els Vanoirbeek, Dr. Aruna V Krishnan, Dr. Ir Guy Eelen, Dr. Lieve Verlinden, Prof. Dr. Roger Bouillon, Prof. Dr. David Feldman, Prof. Dr. Annemieke Verstuyf
Best Pract Res Clin Endocrinol Metab. Author manuscript; available in PMC 2012 August 1.
Published in final edited form as: Best Pract Res Clin Endocrinol Metab. 2011 August; 25(4): 593–604. doi: 10.1016/j.beem.2011.05.001
PMCID:
PMC3164534
Free in PMC on 2012/08/01
A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer
J A Glover, C M Hughes, M M Cantwell, L J Murray
Br J Cancer. 2011 June 28; 105(1): 13–17. Published online 2011 June 7. doi: 10.1038/bjc.2011.204
PMCID:
PMC3137418
Free in PMC on 2012/06/28
Drosophila Eggshell Production: Identification of New Genes and Coordination by Pxt
Tina L. Tootle, Dianne Williams, Alexander Hubb, Rebecca Frederick, Allan Spradling
PLoS One. 2011; 6(5): e19943. Published online 2011 May 26. doi: 10.1371/journal.pone.0019943
PMCID:
PMC3102670
Abstract Full Text PDF–1.4M Supplementary Material
Macrophages induce COX-2 expression in breast cancer cells: role of IL-1β autoamplification
Zhe Hou, Domenick J. Falcone, Kotha Subbaramaiah, Andrew J. Dannenberg
Carcinogenesis. 2011 May; 32(5): 695–702. Published online 2011 February 10. doi: 10.1093/carcin/bgr027
PMCID:
PMC3086701
Abstract Full Text PDF–675K
Exploiting the tumor microenvironment for theranostic imaging
Ioannis Stasinopoulos, Marie-France Penet, Zhihang Chen, Samata Kakkad, Kristine Glunde, Zaver M. Bhujwalla
NMR Biomed. Author manuscript; available in PMC 2012 July 1.
Published in final edited form as: NMR Biomed. 2011 July; 24(6): 636–647. Published online 2011 January 28. doi: 10.1002/nbm.1664
PMCID:
PMC3146040
Free in PMC on 2012/07/01
The Impact of Nutrition on the Development and Prognosis of Breast Cancer
Hans Hauner, Dagmar Hauner
Breast Care (Basel) 2010 December; 5(6): 377–381. Published online 2010 December 8. doi: 10.1159/000322648
PMCID:
PMC3076349
Abstract Full Text PDF–122K
Cytosolic phospholipase A2-α expression in breast cancer is associated with EGFR expression and correlates with an adverse prognosis in luminal tumours
F Caiazza, N S McCarthy, L Young, A D K Hill, B J Harvey, W Thomas
Br J Cancer. 2011 January 18; 104(2): 338–344. Published online 2010 November 30. doi: 10.1038/sj.bjc.6606025
PMCID:
PMC3031888
Abstract Full Text PDF–439K Supplementary Material
Tumor-secreted PGE2 Inhibits CCL5 Production in Activated Macrophages through cAMP/PKA Signaling Pathway
Xuesong Qian, Jidong Zhang, Jianguo Liu
J Biol Chem. 2011 January 21; 286(3): 2111–2120. Published online 2010 November 19. doi: 10.1074/jbc.M110.154971
PMCID:
PMC3023508
Abstract Full Text Supplementary Material
Increasing CD44+/CD24- tumor stem cells, and upregulation of COX-2 and HDAC6, as major functions of HER2 in breast tumorigenesis
Kai-Hung Wang, An-Pei Kao, Chia-Cheng Chang, Jau-Nan Lee, Ming-Feng Hou, Cheng-Yu Long, Hung-Sheng Chen, Eing-Mei Tsai
Mol Cancer. 2010; 9: 288. Published online 2010 November 2. doi: 10.1186/1476-4598-9-288
PMCID:
PMC2989327
Abstract Full Text PDF–2.2M Supplementary Material
Polymorphisms in oxidative stress and inflammation pathway genes, low-dose ionizing radiation, and the risk of breast cancer among US radiologic technologists
Sara J. Schonfeld, Parveen Bhatti, Elizabeth E. Brown, Martha S. Linet, Steven L. Simon, Robert M. Weinstock, Amy A. Hutchinson, Marilyn Stovall, Dale L. Preston, Bruce H. Alexander, Michele M. Doody, Alice J. Sigurdson
Cancer Causes Control. Author manuscript; available in PMC 2011 April 13.
Published in final edited form as: Cancer Causes Control. 2010 November; 21(11): 1857–1866. Published online 2010 August 15. doi: 10.1007/s10552-010-9613-7
PMCID:
PMC3076104
Abstract Full Text PDF–342K
Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study
Theodore M. Brasky, Matthew R. Bonner, Kirsten B. Moysich, Heather M. Ochs-Balcom, Catalin Marian, Christine B. Ambrosone, Jing Nie, Meng Hua Tao, Stephen B. Edge, Maurizio Trevisan, Peter G. Shields, Jo L. Freudenheim
Breast Cancer Res Treat. Author manuscript; available in PMC 2012 February 1.
Published in final edited form as: Breast Cancer Res Treat. 2011 February; 126(1): 157–165. Published online 2010 July 30. doi: 10.1007/s10549-010-1082-x
PMCID:
PMC2992094
Abstract Full Text PDF–337K
Suppression of integrin α3β1 in breast cancer cells reduces COX-2 gene expression and inhibits tumorigenesis, invasion, and crosstalk to endothelial cells
Kara Mitchell, Kimberly B. Svenson, Whitney M. Longmate, Katerina Gkirtzimanaki, Rafal Sadej, Xianhui Wang, Jihe Zhao, Aristides G. Eliopoulos, Fedor Berditchevski, C. Michael DiPersio
Cancer Res. Author manuscript; available in PMC 2011 February 1.
Published in final edited form as: Cancer Res. 2010 August 1; 70(15): 6359–6367. Published online 2010 July 14. doi: 10.1158/0008-5472.CAN-09-4283
PMCID:
PMC2913124
Abstract Full Text PDF–985K Supplementary Material
Specialty Supplements and Breast Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort
Theodore M. Brasky, Johanna W. Lampe, John D. Potter, Ruth E. Patterson, Emily White
Cancer Epidemiol Biomarkers Prev. Author manuscript; available in PMC 2011 July 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 July; 19(7): 1696–1708. doi: 10.1158/1055-9965.EPI-10-0318
PMCID:
PMC2906099
Abstract Full Text PDF–330K Supplementary Material
Overexpression of COX-2 in celecoxib-resistant breast cancer cell lines
Balraj Singh, LaTashia R. Irving, Karen Tai, Anthony Lucci
J Surg Res. Author manuscript; available in PMC 2011 October 1.
Published in final edited form as: J Surg Res. 2010 October; 163(2): 235–243. Published online 2010 May 26. doi: 10.1016/j.jss.2010.04.061
PMCID:
PMC2943002
Abstract Full Text PDF–4.1M
PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-β signaling during mammary tumorigenesis
Maozhen Tian, William P. Schiemann
FASEB J. 2010 April; 24(4): 1105–1116. doi: 10.1096/fj.09-141341
PMCID:
PMC2845432
Abstract Full Text
Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study
Deirdre P Cronin-Fenton, Lars Pedersen, Timothy L Lash, Søren Friis, John A Baron, Henrik T Sørensen
Breast Cancer Res. 2010; 12(2): R15. Published online 2010 March 1. doi: 10.1186/bcr2482
PMCID:
PMC2879557
Abstract Full Text PDF–307K Supplementary Material
PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)
Laure Dossus, Rudolf Kaaks, Federico Canzian, Demetrius Albanes, Sonja I. Berndt, Heiner Boeing, Julie Buring, Stephen J. Chanock, Francoise Clavel-Chapelon, Heather Spencer Feigelson, John M. Gaziano, Edward Giovannucci, Carlos Gonzalez, Christopher A. Haiman, Göran Hallmans, Susan E. Hankinson, Richard B. Hayes, Brian E. Henderson, Robert N. Hoover, David J. Hunter, Kay-Tee Khaw, Laurence N. Kolonel, Peter Kraft, Jing Ma, Loic Le Marchand, Eiliv Lund, Petra H.M. Peeters, Meir Stampfer, Dan O. Stram, Gilles Thomas, Michael J. Thun, Anne Tjonneland, Dimitrios Trichopoulos, Rosario Tumino, Elio Riboli, Jarmo Virtamo, Stephanie J. Weinstein, Meredith Yeager, Regina G. Ziegler, David G. Cox
Carcinogenesis. 2010 March; 31(3): 455–461. Published online 2009 December 4. doi: 10.1093/carcin/bgp307
PMCID:
PMC2832545
Abstract Full Text PDF–104K Supplementary Material
Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy
Silvia Darb-Esfahani, Sibylle Loibl, Berit M Müller, Marc Roller, Carsten Denkert, Martina Komor, Karsten Schlüns, Jens Uwe Blohmer, Jan Budczies, Bernd Gerber, Aurelia Noske, Andreas du Bois, Wilko Weichert, Christian Jackisch, Manfred Dietel, Klaus Richter, Manfred Kaufmann, Gunter von Minckwitz
Breast Cancer Res. 2009; 11(5): R69. Published online 2009 September 16. doi: 10.1186/bcr2363
PMCID:
PMC2790846
Abstract Full Text PDF–795K Supplementary Material
cAMP Stringently Regulates Human Cathelicidin Antimicrobial Peptide Expression in the Mucosal Epithelial Cells by Activating cAMP-response Element-binding Protein, AP-1, and Inducible cAMP Early Repressor
Krishnendu Chakraborty, Palash Chandra Maity, Alok Kumar Sil, Yoshifumi Takeda, Santasabuj Das
J Biol Chem. 2009 August 14; 284(33): 21810–21827. Published online 2009 June 16. doi: 10.1074/jbc.M109.001180
PMCID:
PMC2755907
Abstract Full Text Supplementary Material
X-linked Inhibitor of Apoptosis Protein and Its E3 Ligase Activity Promote Transforming Growth Factor-β-mediated Nuclear Factor-κB Activation during Breast Cancer Progression
Jason R. Neil, Maozhen Tian, William P. Schiemann
J Biol Chem. 2009 August 7; 284(32): 21209–21217. Published online 2009 June 15. doi: 10.1074/jbc.M109.018374
PMCID:
PMC2755844
Abstract Full Text
Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis
Johanna R Reed, Ronald P Leon, Majken K Hall, Kathryn L Schwertfeger
Breast Cancer Res. 2009; 11(2): R21. Published online 2009 April 24. doi: 10.1186/bcr2246
PMCID:
PMC2688950
Abstract Full Text PDF–4.2M Supplementary Material
PPARδ is pro-tumorigenic in a mouse model of COX-2-induced mammary cancer
Mallika Ghosh, Youxi Ai, Kirsi Narko, Zhenglong Wang, Jeffrey M. Peters, Timothy Hla
Prostaglandins Other Lipid Mediat. Author manuscript; available in PMC 2010 April 1.
Published in final edited form as: Prostaglandins Other Lipid Mediat. 2009 April; 88(3-4): 97–100. Published online 2008 December 24. doi: 10.1016/j.prostaglandins.2008.11.004
PMCID:
PMC2662999
Abstract Full Text PDF–1.2M
Modulation of Breast Cancer Risk by Nonsteroidal Anti-inflammatory Drugs
Louise R. Howe, Scott M. Lippman
J Natl Cancer Inst. 2008 October 15; 100(20): 1420–1423. Published online 2008 October 15. doi: 10.1093/jnci/djn347
PMCID:
PMC2567416
Full Text PDF–80K
Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-β through a PGE2-dependent mechanisms
Jason R. Neil, Kyle M. Johnson, Raphael A. Nemenoff, William P. Schiemann
Carcinogenesis. 2008 November; 29(11): 2227–2235. Published online 2008 August 25. doi: 10.1093/carcin/bgn202
PMCID:
PMC2577139
Abstract Full Text PDF–798K
Combination chemoprevention of HER2/neu-induced breast cancer using a COX-2 inhibitor and an RXR-selective retinoid
Powel H. Brown, Kotha Subbaramaiah, Amoi P. Salmon, Rebecca Baker, Robert A. Newman, Peiying Yang, Xi Kathy Zhou, Reid P. Bissonnette, Andrew J. Dannenberg, Louise R. Howe
Cancer Prev Res (Phila) Author manuscript; available in PMC 2009 August 1.
Published in final edited form as: Cancer Prev Res (Phila). 2008 August; 1(3): 208–214. doi: 10.1158/1940-6207.CAPR-08-0021
PMCID:
PMC2612594
Abstract Full Text PDF–276K
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study
Gretchen L Gierach, James V Lacey, Jr, Arthur Schatzkin, Michael F Leitzmann, Douglas Richesson, Albert R Hollenbeck, Louise A Brinton
Breast Cancer Res. 2008; 10(2): R38. Published online 2008 April 30. doi: 10.1186/bcr2089
PMCID:
PMC2397540
Abstract Full Text PDF–206K
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk